There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding ...

The University of Cambridge and the company DIOSynVax have completed the human clinical trial of a universal coronavirus ...

The global health community is locked in an urgent race against time as an Ebola epidemic continues to surge across Africa.

There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway ...

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...

The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a week ago and is already the third-largest on record. But it’s the 17th ...

Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly ...

Dozens of people have died and hundreds have been sickened in an Ebola outbreak centered in the Democratic Republic of the ...

But these events also serve as a reminder that outbreaks are rarely controlled by vaccines alone. While vaccines play an ...